Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
DATE OF REPORT — June 19, 2002
AMERICAN VANGUARD CORPORATION
Delaware (State of incorporation) | 0-6354 (Commission File No.) | 95-2588080 (IRS Employer No.) | ||
4695 MacArthur Court, Newport Beach, California (Address of principal executive offices) | 92660 (Zip Code) |
(949) 260-1200
(Registrant’s telephone number, including area code)
Item 5. Other Events. | ||||||||
Item 7. Exhibits. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.5 |
Table of Contents
Item 5. Other Events.
On June 11, 2002, American Vanguard Corporation issued the press release attached hereto as Exhibit 99.5. The release announced that Amvac Chemical Corporation, a wholly-owned subsidiary of American Vanguard Corporation, has acquired the Folex cotton defoliant business conducted in the United States by Aventis CropScience USA prior to Bayer AG’s acquisition of Aventis CropScience S.A., all as more particularly described in Exhibit 99.5.
Item 7. Exhibits.
99.5 | Press release issued June 11, 2002. |
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERICAN VANGUARD CORPORATION | ||
| ||
Date: June 19, 2002 | By: | /s / J. A. Barry |
J. A. Barry Senior Vice President Chief Financial Officer |
3
Table of Contents
EXHIBIT INDEX
EXHIBIT | ||
NUMBER | DESCRIPTION | |
99.5 | Press Release issued June 11, 2002 |
4